{"pmid":32401410,"title":"Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.","text":["Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.","Dermatol Ther","Litaiem, Noureddine","Hajlaoui, Khaoula","Karray, Manel","Slouma, Maroua","Zeglaoui, Faten","32401410"],"journal":"Dermatol Ther","authors":["Litaiem, Noureddine","Hajlaoui, Khaoula","Karray, Manel","Slouma, Maroua","Zeglaoui, Faten"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32401410","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1111/dth.13565","e_drugs":["Hydroxychloroquine"],"topics":["Treatment"],"weight":1,"_version_":1666714494778212352,"score":9.490897,"similar":[{"pmid":32386448,"title":"Acute Generalized Exanthematous Pustulosis with Erythema Multiforme-Like lesions in a COVID-19 woman.","text":["Acute Generalized Exanthematous Pustulosis with Erythema Multiforme-Like lesions in a COVID-19 woman.","The antimalarials, Chloroquine and Hydroxychloroquine (HCQ), and the antivirals Lopinavir/Ritonavir have been recently recorded as having anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) effects.(1) In particular, regarding Italy, one of the countries most affected by the pandemic, the Italian Society of Infectious and Tropical disease (Lombardy section) has recommended the use of HCQ for treatment of coronavirus disease 2019 (COVID-19).","J Eur Acad Dermatol Venereol","Robustelli Test, E","Vezzoli, P","Carugno, A","Raponi, F","Gianatti, A","Rongioletti, F","Sena, P","32386448"],"abstract":["The antimalarials, Chloroquine and Hydroxychloroquine (HCQ), and the antivirals Lopinavir/Ritonavir have been recently recorded as having anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) effects.(1) In particular, regarding Italy, one of the countries most affected by the pandemic, the Italian Society of Infectious and Tropical disease (Lombardy section) has recommended the use of HCQ for treatment of coronavirus disease 2019 (COVID-19)."],"journal":"J Eur Acad Dermatol Venereol","authors":["Robustelli Test, E","Vezzoli, P","Carugno, A","Raponi, F","Gianatti, A","Rongioletti, F","Sena, P"],"date":"2020-05-10T11:00:00Z","year":2020,"_id":"32386448","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/jdv.16613","keywords":["acute generalized exanthematous pustulosis (agep)","covid-19","drug reaction","hydroxychloroquine (hcq)","skin","severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"],"locations":["Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Case Report"],"weight":1,"_version_":1666340101965217792,"score":80.36008},{"pmid":32455478,"title":"A case of cefditoren-induced Acute Generalized Exanthematous Pustulosis during COVID-19 pandemics. Severe Cutaneous Adverse Reactions (SCARs) are an issue.","text":["A case of cefditoren-induced Acute Generalized Exanthematous Pustulosis during COVID-19 pandemics. Severe Cutaneous Adverse Reactions (SCARs) are an issue.","We read with interest the article by Recalcati et al. about the report of cutaneous manifestations in COVID-19 patients. We would like to highlight that some potentially severe manifestations in these patients are not directly related to the coronavirus but to the medications administered.","J Eur Acad Dermatol Venereol","Torres-Navarro, Ignacio","Abril-Perez, Carlos","Roca-Gines, Juncal","Sanchez-Arraez, Javier","Botella-Estrada, Rafael","32455478"],"abstract":["We read with interest the article by Recalcati et al. about the report of cutaneous manifestations in COVID-19 patients. We would like to highlight that some potentially severe manifestations in these patients are not directly related to the coronavirus but to the medications administered."],"journal":"J Eur Acad Dermatol Venereol","authors":["Torres-Navarro, Ignacio","Abril-Perez, Carlos","Roca-Gines, Juncal","Sanchez-Arraez, Javier","Botella-Estrada, Rafael"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32455478","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/jdv.16664","keywords":["acute generalized exanthematous pustulosis (agep)","covid-19","sars-cov-2","severe cutaneous adverse reactions (scars)"],"e_drugs":["cefditoren"],"topics":["Treatment"],"weight":1,"_version_":1667983494515523585,"score":68.33905}]}